261 related articles for article (PubMed ID: 6351057)
21. Transient inhibition of DNA synthesis by 5-fluorodeoxyuridine leads to overexpression of dihydrofolate reductase with increased frequency of methotrexate resistance.
Schuetz JD; Gorse KM; Goldman ID; Westin EH
J Biol Chem; 1988 Jun; 263(16):7708-12. PubMed ID: 2967290
[TBL] [Abstract][Full Text] [Related]
22. Responses of human cervical keratinocytes in vitro to tumour promoters and diethylstilboestrol.
Stanley MA; Crowcroft NS; Quigley JP; Parkinson EK
Carcinogenesis; 1985 Jul; 6(7):1011-5. PubMed ID: 2410159
[TBL] [Abstract][Full Text] [Related]
23. X-ray induction of methotrexate resistance due to dhfr gene amplification.
Hahn P; Nevaldine B; Morgan WF
Somat Cell Mol Genet; 1990 Sep; 16(5):413-23. PubMed ID: 2122527
[TBL] [Abstract][Full Text] [Related]
24. [Mechanisms of development of resistance to methotrexate in choriocarcinoma cells].
Sakai K
Hokkaido Igaku Zasshi; 1986 Sep; 61(5):649-61. PubMed ID: 3781466
[TBL] [Abstract][Full Text] [Related]
25. Induction of erythroleukemia cell adhesion by plant diterpene tumour promoters: a quantitative study and correlation with in vivo activities.
Yamasaki H; Weinstein IB; Van Duuren BL
Carcinogenesis; 1981; 2(6):537-43. PubMed ID: 6944162
[TBL] [Abstract][Full Text] [Related]
26. Dihydrofolate reductase amplification and sensitization to methotrexate of methotrexate-resistant colon cancer cells.
Morales C; García MJ; Ribas M; Miró R; Muñoz M; Caldas C; Peinado MA
Mol Cancer Ther; 2009 Feb; 8(2):424-32. PubMed ID: 19190117
[TBL] [Abstract][Full Text] [Related]
27. A rapid, simple screening method for skin-tumor promoters using mouse peritoneal macrophages in vitro.
Ohkawa Y; Iwata K; Shibuya H; Fujiki H; Inui N
Cancer Lett; 1984 Jan; 21(3):253-60. PubMed ID: 6692344
[TBL] [Abstract][Full Text] [Related]
28. Nature of the epidermal hyperplasia produced by mezerein, a weak tumor promoter, in initiated skin of mice.
Argyris TS
Cancer Res; 1983 Apr; 43(4):1768-73. PubMed ID: 6403228
[No Abstract] [Full Text] [Related]
29. Differential susceptibility to carcinogen-induced amplification of SV40 and dhfr sequences in SV40-transformed human keratinocytes.
Rossman TG; Wolosin D
Mol Carcinog; 1992; 6(3):203-13. PubMed ID: 1332730
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the expression of a mutant dihydrofolate reductase under control of different internal promoters in retroviral vectors.
Li M; Hantzopoulos PA; Banerjee D; Zhao SC; Schweitzer BI; Gilboa E; Bertino JR
Hum Gene Ther; 1992 Aug; 3(4):381-90. PubMed ID: 1525211
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of N-methyl-N'-nitro-N-nitrosoguanidine-induced methotrexate and adriamycin resistance in CHO cells by adeno-associated virus type 2.
Yalkinoglu AO; Schlehofer JR; zur Hausen H
Int J Cancer; 1990 Jun; 45(6):1195-203. PubMed ID: 2161803
[TBL] [Abstract][Full Text] [Related]
32. Amplification of a polymorphic dihydrofolate reductase gene expressing an enzyme with decreased binding to methotrexate in a human colon carcinoma cell line, HCT-8R4, resistant to this drug.
Srimatkandada S; Schweitzer BI; Moroson BA; Dube S; Bertino JR
J Biol Chem; 1989 Feb; 264(6):3524-8. PubMed ID: 2914962
[TBL] [Abstract][Full Text] [Related]
33. Effects of tumor promoters on the frequency of metallothionein I gene amplification in cells exposed to cadmium.
Hayashi K; Fujiki H; Sugimura T
Cancer Res; 1983 Nov; 43(11):5433-6. PubMed ID: 6616475
[TBL] [Abstract][Full Text] [Related]
34. Effect of phorbol esters on the activity of purified transforming growth factors.
Kraft AS
Cancer Res; 1986 Apr; 46(4 Pt 1):1764-7. PubMed ID: 3004705
[TBL] [Abstract][Full Text] [Related]
35. Molecular mechanisms of resistance to antifolates, a review.
Banerjee D; Ercikan-Abali E; Waltham M; Schnieders B; Hochhauser D; Li WW; Fan J; Gorlick R; Goker E; Bertino JR
Acta Biochim Pol; 1995; 42(4):457-64. PubMed ID: 8852336
[TBL] [Abstract][Full Text] [Related]
36. [Localization of dihydrofolate reductase amplified genes in Chinese hamster cells resistant to methotrexate].
Mukhamedkhanova FS; Kuznetsova NN; Nuridzhaniants SS; Abdurkarimov AA
Genetika; 1987 Sep; 23(9):1588-94. PubMed ID: 3692154
[TBL] [Abstract][Full Text] [Related]
37. Enhancement of the frequency of methotrexate resistance by gamma-radiation in Chinese hamster ovary and mouse 3T6 cells.
Sharma RC; Schimke RT
Cancer Res; 1989 Jul; 49(14):3861-6. PubMed ID: 2736529
[TBL] [Abstract][Full Text] [Related]
38. Selection for methotrexate resistance in mammalian cells bearing a Drosophila dihydrofolate reductase transgene: Methotrexate resistance in transgenic mammalian cells.
Affleck JG; Nowickyj SM; Walker VK
Cell Biol Toxicol; 2010 Apr; 26(2):117-26. PubMed ID: 19337845
[TBL] [Abstract][Full Text] [Related]
39. Modulation of protein kinase C activity and [3H]phorbol 12,13-dibutyrate binding by various tumor promoters in mouse brain cytosol.
Leach KL; Blumberg PM
Cancer Res; 1985 May; 45(5):1958-63. PubMed ID: 3157441
[TBL] [Abstract][Full Text] [Related]
40. Selective overproduction of human dihydrofolate reductase in a methotrexate-resistant human-mouse somatic cell hybrid.
Sastry KJ; Chan TS; Rodriguez LV
Biochem Biophys Res Commun; 1985 Oct; 132(2):795-803. PubMed ID: 4062946
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
